Related Experiment Video
Updated: Mar 19, 2026

11:22
Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
Published on: June 27, 2018
8.5K
Sequence Context Influences the Structure and Aggregation Behavior of a PolyQ Tract.
Bahareh Eftekharzadeh1, Alessandro Piai2, Giulio Chiesa1
1Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Biophysical Journal
|June 9, 2016
Summary
Polyglutamine (polyQ) diseases are caused by expanded polyQ tracts. A Leu-rich region in androgen receptor protein was found to protect against aggregation, offering new therapeutic targets for polyQ diseases.
Area of Science:
- Neurodegenerative diseases
- Protein aggregation
- Molecular biology
Background:
- Expansions of polyglutamine (polyQ) tracts in proteins cause neurodegenerative polyQ diseases.
- Understanding polyQ tract conformation and aggregation is crucial for therapeutic development.
- Spinobulbar muscular atrophy (Kennedy disease) is a polyQ disease linked to androgen receptor mutations.
Purpose of the Study:
- To investigate the structural conformation of polyQ tracts within their native sequence context.
- To determine how flanking sequences influence polyQ tract aggregation.
- To identify potential therapeutic strategies for polyQ diseases.
Main Methods:
- Solution Nuclear Magnetic Resonance (NMR) spectroscopy.
- Single-residue resolution analysis.
- Study of a 156-residue androgen receptor fragment.
Main Results:
- A Leu-rich region preceding the polyQ tract induced an alpha-helical conformation.
- This helical structure appeared to protect the protein fragment from aggregation.
- This represents a novel mechanism for sequence context to mitigate harmful polyQ properties.
Conclusions:
- Flanking sequences, specifically Leu-rich regions, can significantly alter polyQ tract behavior.
- The protective effect against aggregation suggests new therapeutic avenues.
- Targeting residues flanking polyQ tracts may be a viable strategy for drug discovery in polyQ diseases.
Related Concept Videos
Protein Organization
161.0K
Overview
161.0K
Protein Organization
9.9K
Proteins are polymers of amino acid residues. They are versatile and responsible for different cellular functions, including DNA replication, molecular transport, catalysis, and structural support. Proteins have a hierarchical structure comprising at least three levels of organization: primary, secondary, and tertiary structure. Some large proteins have a quaternary structure where individual protein subunits are linked together.
The primary structure of a protein is its amino acid sequence....
The primary structure of a protein is its amino acid sequence....
9.9K
Protein Folding
130.0K
Overview
130.0K
Protein Folding
12.1K
Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
12.1K
Amyloid Fibrils
12.8K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.8K
Protein Folding Quality Check in the RER
5.4K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
5.4K

